MDPI开放科学分享 http://blog.sciencenet.cn/u/mdpi https://www.mdpi.com/

博文

Cancers 文献清单:“癌症诊断与生物标志物”方向

已有 203 次阅读 2026-4-8 17:38 |个人分类:文献清单|系统分类:论文交流

还在为筛选文献而发愁?别急,这份“癌症诊断与生物标志物”方向的文献清单,也许能为你提供灵感!

   

01

Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma

血清中CA125和HE4水平作为预测子宫内膜癌区域淋巴结转移情况的指标

https://www.mdpi.com/2072-6694/17/17/2740

   

02

L1CAM Reliably Distinguishes Low-Grade Oncocytic Tumor from Other Eosinophilic Renal Neoplasms: A Multicenter Immunohistochemical Study with Diagnostic Implications

L1CAM在区分低度恶性嗜酸细胞性肿瘤与其他嗜酸性肾肿瘤中的可靠性:一项具有诊断意义的多中心免疫组织化学研究

https://www.mdpi.com/2072-6694/17/15/2440

   

03

Historic p87 Is Diagnostic for Lung Cancer Preceding Clinical Presentation by at Least 4 Years

p87标志物可在肺癌临床症状出现至少4年前用于疾病诊断

https://www.mdpi.com/2072-6694/17/6/952

   

04

Comparative Analysis of Bone Marrow, cfDNA and CTCs for NGS-Based Multiple Myeloma Detection: A Pilot Study Indicating the Potential of CTCs

基于高通量测序技术检测多发性骨髓瘤:骨髓、cfDNA与CTCs的比较分析—一项揭示CTCs潜力的初步研究

https://www.mdpi.com/2072-6694/17/24/4008

   

05

Methylation-Mediated Silencing of miR-124-3 Regulates LRRC1 Expression and Promotes Oral Cancer Progression

miR-124-3甲基化介导的沉默调控LRRC1表达并促进口腔癌进展

https://www.mdpi.com/2072-6694/17/7/1136

  

06

The Role of CA125 and HE4 in Uterine Sarcomas: Beyond Diagnosis and Prognosis—A Systematic Review and Case Series from a Single Institution

突破诊断与预后局限:CA125和HE4在子宫肉瘤中的多元作用——单机构系统评价与病例系列研究

https://www.mdpi.com/2072-6694/17/9/1473

  

07

Osteopontin Expression and Its Role in Endometrial Cancer: A Systematic Review

骨桥蛋白表达及其在子宫内膜癌中的作用

https://www.mdpi.com/2072-6694/17/13/2245

   

08

Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study

确诊初期前列腺癌患者中单克隆丙种球蛋白病的患病率:一项相关性前瞻性观察研究

https://www.mdpi.com/2072-6694/17/23/3790

  

09

The Genomic Landscape of Romanian Non-Small Cell Lung Cancer Patients: The Insights from Routine NGS Testing with the Oncomine™ Dx Express Test at the PATHOS Molecular Pathology Laboratory

基于罗马尼亚PATHOS分子病理实验室常规NGS检测的罗马尼亚非小细胞肺癌患者基因组图谱分析

https://www.mdpi.com/2072-6694/17/12/1947

  

10

Microsatellite Instability as a Risk Factor for Occult Lymph Node Metastasis in Early-Stage Endometrial Cancer: A Retrospective Multicenter Study

微卫星不稳定性作为早期子宫内膜癌隐匿性淋巴结转移的危险因素:一项回顾性多中心研究

https://www.mdpi.com/2072-6694/17/7/1162

   

11

Molecular Diagnosis, Clinical Trial Representation, and Precision Medicine in Minority Patients with Oncogene-Driven Lung Cancer

致癌驱动基因型肺癌少数族裔患者的分子诊断、临床试验代表性及精准医疗

https://www.mdpi.com/2072-6694/17/12/1950

  

12

Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review

CLDN18.2与胃癌肿瘤微环境的相关性

https://www.mdpi.com/2072-6694/17/13/2120

   

13

Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma

胸膜间皮瘤病理诊断中的挑战

https://www.mdpi.com/2072-6694/17/3/481

  

14

The Diagnostic Accuracy of the Paris System for Reporting Upper Urinary Tract Cytology: The Atypical Urothelial Cell Conundrum

巴黎系统报告上尿路细胞学的诊断准确性:非典型尿路上皮细胞难题解析

https://www.mdpi.com/2072-6694/17/7/1097

   

15

The Importance and Challenges of Early Diagnosis of Paraneoplastic Skin Syndromes in Cancer Detection—A Review

副肿瘤性皮肤综合征在肿瘤早期诊断中的重要意义与挑战

https://www.mdpi.com/2072-6694/17/7/1053

   

  • Cancers 期刊介绍

主编:Samuel C. Mok, The University of Texas MD Anderson Cancer Center, USA

期刊主题涵盖癌症治疗和免疫疗法、癌症生物标志物、流行病学和预防、肿瘤微环境、癌症病因和筛查、诊断和护理、癌症分子生物学等肿瘤学领域的各个方面。目前,期刊已被SCIE、Scopus、PubMed等重要数据库收录。

2024 Impact Factor:4.4

2024 CiteScore:8.8

Time to First Decision:19.1 Days

Acceptance to Publication:2.6 Days

期刊主页:https://www.mdpi.com/journal/cancers

2026-01-20_banner 2 (1).jpg



https://blog.sciencenet.cn/blog-3516770-1529501.html

上一篇:Pharmacy:乌司奴单抗治疗克罗恩病——临床疗效和安全性综述
下一篇:对话Biomedicines参会旅行奖获得者——Kristin Schüler博士 | MDPI 人物专访
收藏 IP: 123.151.207.*| 热度|

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2026-4-9 00:00

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部